-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Annovis Bio, Lowers Price Target to $12

Benzinga·06/09/2025 12:00:13
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target from $30 to $12.